F-group (family)
10.1.1.4 Gal-bind_lectin
Ligands and drugs
1,179
Member domains
487
with ligand contacts (≤ 4 Å)
41.3% of members
439
with DrugDomain annotations
37.2% of members
263
with a DrugBank compound
22.3% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 10.1.1.4 belongs to X-group 10 jelly-roll, which binds 8.5 ligand superclasses per 20 proteins, broader than 66% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03345 | BME | Mercaptoethanol | 35 |
| DB12895 | TD2 | Olitigaltin | 14 |
| DB02379 | BGC | Beta-D-Glucose | 7 |
| DB02175 | MLA | Malonic acid | 2 |
| DB02678 | 1GN | beta-D-Galactosamine | 2 |
| DB04447 | DTT | 1,4-Dithiothreitol | 2 |
| DB14128 | NAD | Nadide | 2 |
| DB01827 | BEK | 2,3,5,6-Tetrafluoro-4-Methoxy-Benzamide | 1 |
| DB02184 | DTV | D-1,4-dithiothreitol | 1 |
| DB02967 | NEQ | N-Ethylmaleimide | 1 |
| DB02983 | PMB | Para-Mercury-Benzenesulfonic Acid | 1 |
| DB03283 | FUL | beta-L-fucose | 1 |
| DB03989 | ALL | D-Allopyranose | 1 |
| DB04286 | RIP | beta-D-Ribopyranose | 1 |
| DB04396 | — | — | 1 |
| DB04465 | — | — | 1 |
| DB11638 | — | — | 1 |
| DB13123 | — | — | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| CL | CHLORIDE ION | 85 |
| BME | BETA-MERCAPTOETHANOL | 35 |
| SCN | THIOCYANATE ION | 24 |
| TD2 | 3-deoxy-3-[4-(3-fluorophenyl)-1H-1,2,3-triazol-1-yl]-beta-D-galactopyranosyl 3-deoxy-3-[4-(3-fluorophenyl)-1H-1,2,3-triazol-1-yl]-1-thio-beta-D-galactopyranoside | 14 |
| BGC | beta-D-glucopyranose | 13 |
| GAL | beta-D-galactopyranose | 13 |
| MGmetal | MAGNESIUM ION | 13 |
| NAmetal | SODIUM ION | 7 |
| NImetal | NICKEL (II) ION | 7 |
| BR | BROMIDE ION | 6 |
| CAmetal | CALCIUM ION | 6 |
| ZNmetal | ZINC ION | 5 |
| 4S0 | DENDRON D2-1 | 4 |
| LBL | (2~{R},3~{R},4~{R},5~{R})-4-[(2~{S},3~{R},4~{S},5~{R},6~{R})-6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-2,3,5,6-tetrakis(oxidanyl)hexanal | 4 |
| LSE | 2-(trimethylsilyl)ethyl 4-O-beta-D-galactopyranosyl-6-Se-methyl-6-seleno-beta-D-glucopyranoside | 4 |
| YIO | 1-thio-beta-D-galactopyranose | 4 |
| 5KT | 3-deoxy-3-[4-(thiophen-3-yl)-1H-1,2,3-triazol-1-yl]-beta-D-galactopyranosyl 3-deoxy-1-thio-3-[4-(thiophen-3-yl)-1H-1,2,3-triazol-1-yl]-beta-D-galactopyranoside | 3 |
| A1L0Q | (2~{S},3~{R},4~{R},5~{R},6~{R})-4-[4-[4-chloranyl-3,5-bis(fluoranyl)phenyl]-1,2,3-triazol-1-yl]-2-[4-[5-chloranyl-2-(trifluoromethyl)phenyl]-5-methyl-1,2,4-triazol-3-yl]-6-(hydroxymethyl)oxane-3,5-diol | 3 |
| H5O | (2R,3R,4S,5R,6S)-2-(hydroxymethyl)-5-methoxy-6-[(3R,4R,5S)-4-oxidanyl-5-(4-pyrimidin-5-yl-1,2,3-triazol-1-yl)oxan-3-yl]sulfanyl-4-[4-[3,4,5-tris(fluoranyl)phenyl]-1,2,3-triazol-1-yl]oxan-3-ol | 3 |
| YNO | 5-bromanyl-3-[(2~{R},3~{R},4~{S},5~{R},6~{R})-4-[4-(4-chloranyl-1,3-thiazol-2-yl)-1,2,3-triazol-1-yl]-6-(hydroxymethyl)-3-methoxy-5-oxidanyl-oxan-2-yl]sulfanyl-pyridine-2-carbonitrile | 3 |